Fulcrum Therapeutics Inc.

NASDAQ: FULC · Real-Time Price · USD
6.81
0.21 (3.18%)
At close: Aug 15, 2025, 3:59 PM
6.82
0.15%
After-hours: Aug 15, 2025, 04:10 PM EDT

Fulcrum Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Net Income
-73.22M -510K -9.72M -17.91M -20.23M -99.43M -97.33M -98.72M -98.44M -108.72M -109.87M -107.22M -104.2M -89.78M -80.85M -75.08M -73.33M
Depreciation & Amortization
1.44M 1.47M 1.59M 1.73M 1.89M 2.08M 2.17M 2.25M 2.33M 2.44M 2.41M 2.44M 2.45M 2.45M 2.52M 2.63M 2.56M
Stock-Based Compensation
12.34M 13.8M 14.55M 15.53M 15.45M 14.46M 14.8M 14.62M 14.24M 13.76M 13.35M 13.87M 13.18M 12.84M 11.07M 8.95M 8.07M
Other Working Capital
130K 327K -1.27M -575K -4.63M -4.21M -3.93M -1.41M -6.14M -8.05M -6.72M -10.84M -9.22M -9.15M -12.36M -15.25M 1.15M
Other Non-Cash Items
-5.12M -6.51M -3.31M 1.55M 3.27M 2.69M -752K -5.26M -3.57M -2.74M -1.02M -38K -58K 952K 673K 322K 213K
Deferred Income Tax
n/a n/a n/a -5.24M -5.24M -5.24M -5.24M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-573K -669K -2.09M -1.03M -4.35M -3.47M -4.61M -403K -7.05M -4.97M -3.09M -9.45M -6.45M -10.83M -11.89M -13.27M 4.11M
Operating Cash Flow
-64.91M 7.81M -2.22M -8.62M -12.45M -92.13M -90.97M -87.5M -92.48M -99.06M -97.05M -99.21M -93.9M -84.36M -78.48M -76.45M -58.38M
Capital Expenditures
-315K -250K -278K -124K -170K -365K -508K -547K -765K -1.89M -1.96M -2.37M -2.45M -1.7M -1.71M -1.67M -1.39M
Cash Acquisitions
n/a n/a n/a -18.43M 36.62M 110.68M 204.45M 259.13M 206.08M 132.01M 38.24M 2M n/a n/a n/a n/a n/a
Purchase of Investments
-196.33M -183.18M -178.59M -182.26M -170.11M -124.2M -194.89M -253.11M -279.82M -272.67M -151.15M -102.75M -179.62M -218.23M -216.23M -224.35M -103.4M
Sales Maturities Of Investments
216.41M 176.75M 211.1M 230.71M 233.28M 219.95M 158.71M 162.25M 167.88M 173.37M 165.53M 144.8M 117.39M 97.5M 88.28M 90.84M 90.35M
Other Investing Acitivies
n/a n/a 38.16M 56.59M 1.54M -72.53M -204.45M -259.13M -206.08M -99.3M 14.38M 42.05M -62.23M -120.73M -127.96M -133.51M -13.05M
Investing Cash Flow
19.77M -6.67M 32.23M 48.32M 62.99M 95.38M -36.69M -91.41M -112.71M -101.19M 12.41M 39.68M -64.68M -122.42M -129.67M -135.17M -14.45M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1K n/a -5K -18K -30K -44K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -193K -193K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
718K 1.09M 2.75M 2.95M 2.31M 2.08M 777K 708K 801K 3.47M 3.47M 4.14M 6.43M 3.83M 3.57M 3.21M 927K
Financial Cash Flow
1.02M 1.09M 2.75M 2.95M 120.15M 119.92M 235.96M 235.89M 199M 201.67M 84.32M 85M 141.95M 139.35M 186.51M 191.87M 53.88M
Net Cash Flow
-44.13M 2.21M 32.63M 42.53M 52.74M 5.21M -9.54M -60.86M -6.19M 1.42M -314K 25.46M -16.63M -67.43M -21.64M -19.75M -18.94M
Free Cash Flow
-65.22M 7.56M -2.5M -8.74M -12.62M -92.5M -91.47M -88.05M -93.24M -100.95M -99.01M -101.58M -96.35M -86.06M -80.19M -78.11M -59.77M